BioSpace News Archive

Business

Applied DNA Awarded Multi-Year Contract to Develop Molecular Tracking Systems for Legal Cannabis Worldwide

Applied DNA Sciences, Inc. today announced the signing of an initial two-year, $1 million contract with TheraCann International Benchmark Corporation.

January 25, 2018
·
6 min read
Drug Development

The Medicines Company Release: Inclisiran’s First Pivotal Trial Achieves Target Enrollment Ahead of Schedule

The Medicines Company today announced that the target of 1,500 patients randomized in the ORION-11 trial has been exceeded in 11 weeks – considerably beating its goal of 28 weeks.

January 25, 2018
·
6 min read
Business

Celgene Reports Fourth Quarter and Full-Year 2017 Operating and Financial Results

For the fourth quarter of 2017, net product sales were $3,479 million, an increase of 17 percent, year-over-year.

January 25, 2018
·
33 min read
Business

Ellen M. Zane Rejoins Haemonetics Board of Directors

Haemonetics announced the election of Ellen M. Zane to its Board of Directors. Zane is a nationally renowned health care leader with more than 30 years of experience in hospitals and health care systems.

January 25, 2018
·
2 min read
Business

Stellar Biotechnologies Appoints Pharma Licensing Expert to Board of Directors

Stellar Biotechnologies today announced the appointment of Deborah F. Aghib, Ph.D. to the company’s Board of Directors.

January 25, 2018
·
4 min read
Business

Prokaryotics Announces Licensing Agreement With Merck for Novel Investigational Antibiotic Candidates

Specific terms of the agreement were not disclosed.

January 25, 2018
·
2 min read
Business

JDRF Partners with EOFlow to Develop Wearable Automated Insulin Delivery System for People With Type 1 Diabetes

The product incorporates a proprietary electroosmotic pumping technology which allows it to be smaller and lighter.

January 25, 2018
·
4 min read
Business

Medidata Schedules Fourth Quarter Earnings Conference Call for February 8, 2018

Medidata today announced that it will release its fourth quarter 2017 financial results before the open of the market on Thursday, February 8, 2018.

January 25, 2018
·
2 min read
Bio NC

Liquidia Presents Positive LIQ861 Results at the Annual World Congress of the Pulmonary Vascular Research Institute

Liquidia today announced positive Phase 1 and preclinical results evaluating LIQ861 for the treatment of PAH at the 12th Pulmonary Vascular Research Institute (PVRI) Annual World Congress on Pulmonary Vascular Disease in Singapore.

January 25, 2018
·
5 min read
Bio NC

CEM Launches the Liberty PRIME Peptide Synthesizer

CEM Corporation is proud to announce the release of the new Liberty PRIME automated microwave peptide synthesizer.

January 25, 2018
·
2 min read